Clinical Trial Update: Vascular Endothelial Growth Factor (VEGF) Levels in Brain Tumor Patients

View source ↗

Summary

A clinical trial investigating Vascular Endothelial Growth Factor (VEGF) levels in brain tumor patients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioma
• Meningioma

Snippet

Sponsor: Marquette General Health System | Conditions: Glioma, Meningioma | Status: WITHDRAWN